Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Consumer Transparency topic

No spam. Unsubscribe anytime.

Committee sends product‑labeling transparency RS to print after brief questions

Judiciary & Rules · February 16, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Senator Ben Toews presented RS33394, a proposal to require labeling for products that used fetal tissue in research or production. The committee voted to send the RS to print; Senator Wintrow was recorded as voting nay.

Senator Ben Toews (District 4) told the Judiciary & Rules Committee that RS33394 is "a transparency bill, essentially requiring labeling for any products that have used fetal tissue or in the research or in the production of products sold in Idaho." He asked the committee to print the RS for a fuller hearing.

Senator Ricks said he would vote to print but asked for scenarios where the legislation would apply, citing cosmetics and medical-industry uses. Senator Wintrow asked that proponents be prepared to discuss the benefits of biomedical research during a full hearing. A motion to send RS33394 to print was made and carried; the chair recorded Senator Wintrow as voting nay. The committee did not take testimony today; proponents will have the opportunity to provide more information at a printed hearing.